Changes in tenascin-C isoform expression in invasive and preinvasive breast disease

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3289-3297

  Adams, Matthew ^a   Jones, J Louise ^a   Walker, Rosemary A ^a   Pringle, J Howard ^a   Bell, Stephen C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TENASCIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; CELL MIGRATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR WEIGHT; MYOEPITHELIUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STROMA;

ALTERNATIVE SPLICING; BLOTTING, SOUTHERN; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; HUMANS; IN SITU HYBRIDIZATION; NEOPLASM INVASIVENESS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TENASCIN; TUMOR CELLS, CULTURED;

EID: 0036606644     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Stromal regulation of epithelial function
2. Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signalling ligands
3. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5
4. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis
5. Alteration of stromal protein and integrin expression in breast - A marker of premalignant change?
6. The tenascin family of ECM glycoproteins: Structure, function and regulation during embryonic development and tissue remodelling
7. Tenascin expression in cancer cells and stroma of human breast and its prognostic significance
8. Tenascin-C expression in invasion border of early breast cancer: A predictor of local and distant recurrence
9. Expression of tenascin-C in intraductal carcinoma of human breast: Relationship to invasion
10. Tenascin patterns of expression in duct carcinoma in situ of the breast
11. Tenascin variants: Differential binding to fibronectin and distinct distribution in cell cultures and tissue
12. Domains of tenascin involved in glioma migration
13. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines
14. Focal adhesion integrity is down-regulated by the alternatively spliced domain of human tenascin
15. Mitogenesis, cell migration and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor annexin II
16. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor
17. Elastase and matrix metalloproteinase inhibitors induce regression and tenascin-C antisense prevents progression of vascular disease
18. The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation
19. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts
20. Extracellular matrix and tenascin-C in pathogenesis of breast cancer
21. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases
22. Tenascin-C inhibits extracellular matrix dependent gene expression in mammary epithelial cells. Localisation of active regions using recombinant fragments
23. Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain
24. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast
25. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma
26. Detection of tenascin-C isoforms in cotorectal mucosa, ulcerative colitis, carcinomas and liver metastases
27. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
28. Amplification of specific mRNA from a single human renal glomerulus, with an approach to the separation of epithelial cell mRNA
29. Detection of specific sequences among DNA fragments separated by gel electrophoresis
30. Production and characterisation of monoclonal antibodies specific for different epitopes of human tenascin
31. The use of polymerase chain reaction generated nucleotide sequences as probes for hybridisation
32. Regional and cellular localization of osteonectin/SPARC expression in connective tissue and cytotrophoblastic layers of human fetal membranes at term
33. A rapid in vitro assay for quantitating the invasive potential of tumour cells
34. Modulation of the myoepithelial associated α6β4 integrin in a breast cancer cell line alters invasive potential
35. Human tenascin: Primary structure, pre-mRNA splicing patterns and localisation of the epitopes recognised by two monoclonal antibodies
36. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal adult and tumour tissues
37. Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system
38. Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice
39. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours
40. Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes
41. Novel tenascin variants with a distinctive pattern of expression in the avian embryo
42. Human Tenascin-C: Identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosa
43. The expression of tenascin-C with the AD 1 variable repeat in embryonic tissues, cell lines and tumours in various vertebrate species
44. Tenascin - A marker for the malignant potential of preinvasive breast cancers
45. Epithelial cells are an important source of tenascin in normal and malignant breast tissue
46. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: Correlation with histopathological parameters, hormone receptors and oncogenes
47. MTI-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells
48. Phase I trial results of iodine-131-labelled anti-tenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas